TSH Biopharm Corporation Limited (TPEX:8432) agreed to acquire an unknown stake in TOP Pharm. Medicalware Company Limited from Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd., ANIMATO INTERNATIONAL COMPANY, Shen Feng Co., Ltd. and others for TWD 257.1 million on March 11, 2024. Jing-Jun Lu of Ezone CPAs Firm acted as the accountant of TSH Biopharm Corporation Limited.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
60.3 TWD | +2.20% | +10.24% | +19.88% |
Mar. 11 | TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024 | CI |
Mar. 11 | TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+19.88% | 70.98M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 8432 Stock
- News TSH Biopharm Corporation Limited
- TSH Biopharm Corporation Limited agreed to acquire an unknown stake in TOP Pharm. Medicalware Company Limited from Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd., ANIMATO INTERNATIONAL COMPANY, Shen Feng Co., Ltd. and others for TWD 257.1 million.